Sector
PharmaceuticalsCMP
as on 03 Jul, 2024 12:00:00 AM
Open
₹649.9Prev. Close
₹647.3Turnover(Lac.)
₹1,621.7Day's High
₹653Day's Low
₹61952 Week's High
₹662.852 Week's Low
₹320.3Book Value
₹180.88Face Value
₹5Mkt Cap (₹ Cr.)
5,642.38P/E
28.17EPS
22.14Divi. Yield
0.484 May 2024
12:00 AM
Board Meeting
Agenda : Audited Result
21 Aug 2023
12:00 AM
AGM
Announcement Date: 21 Aug, 2023
7 Feb 2024
12:00 AM
Dividend
Dividend Amount: 2
Record Date: 19 Feb, 2024
| Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|
Equity Capital | 45.31 | 45.56 | 0.25 | 0.25 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,393.27 | 1,238.71 | -0.02 | -0.02 |
Net Worth | 1,438.58 | 1,284.27 | 0.23 | 0.23 |
Minority Interest |
No Record found
No Record found
No Record found
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Gross Sales | 1,852.61 | 1,945.23 | 1,199.94 | 0 |
Excise Duty | 0 | 0 | 0 | 0 |
Net Sales | 1,852.61 | 1,945.23 | 1,199.94 | 0 |
Other Operating Income | 0 | 0 | 0 | 0 |
Other Income | 4.9 | 2.32 | 2.51 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,525.25 | 120.29 | 3,65,682.64 | 867.6 | 0.89 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,574.25 | 76.97 | 1,21,312.5 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,488.95 | 32.36 | 1,20,195.02 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,104 | 31.35 | 1,08,114.81 | 1,405.2 | 0.28 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,430 | 24.48 | 1,06,298.05 | 1,034.8 | 0.63 | 5,081.8 | 1,453.02 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Rashesh C Gogri
Vice Chairperson & MD
Hetal Gogri Gala
Managing Director
Narendra Jagannath Salvi
Non-Exec & Non-Independent Dir
Rajendra V Gogri
Non Executive Director
Parimal H Desai
Independent Director
Bhavesh R Vora
Independent Director
Vinay Gopal Nayak
Independent Director
Vilas G Gaikar
Independent Director
Jeenal Savla
Independent Director
Rupal Vora
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Aarti Pharmalabs Ltd
Summary
Aarti Pharmachem Limited was incorporated as a Public Limited Company in 2019. The Company is engaged in manufacturer of Active Pharmaceutical Ingredients (API), Pharmaceutical Intermediates, New Chemical Entities (NCE), and Xanthine Derivatives situated in India.In 2001, the Company commissioned first API manufacturing Unit in Dombivali (Unit 1) and started Xanthine Unit; further it commissioned first API manufacturing Unit 4 in Tarapur for Regulated Markets in 2005; commissioned Caffeine production at Unit 5 with a capacity of 100 Metric Tonnes (MT) per month in 2016. It expanded block for CSD, Vapi and API, Tarapur units in 2022.The Scheme of Arrangement for the demerger of Pharma Business Undertaking from Aarti Industries Limited into its wholly owned subsidiary Aarti Pharmalabs Limited was effective on October 17, 2022 and operational from July 1, 2021. Pursuant to the said Demerger Scheme, Aarti Industries Limited hived off its Pharmaceutical Division into a separate entity Aarti Pharmalabs Limited and accordingly, all the assets and liabilities pertaining to the Pharma Business Undertaking got transferred and vested into the Company effective from the above said Date.Thereafter, the Company in 2023 commercialised Block V at Tarapur Unit 4. Again, it enhanced Xanthine capacity to 5,000 TPA in 2023.9,06,26,008 Equity Shares of Rs 5/- each got listed effective January 30, 2023.
Read More
What is the Aarti Pharmalabs Ltd share price today?
The Aarti Pharmalabs Ltd shares price on nse is Rs.₹622.6 today.
What is the Market Cap of Aarti Pharmalabs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Aarti Pharmalabs Ltd is ₹5642.38 Cr. as of 03 Jul ‘24
What is the PE and PB ratio of Aarti Pharmalabs Ltd?
The PE and PB ratios of Aarti Pharmalabs Ltd is 28.17 and 3.49 as of 03 Jul ‘24
What is the 52 Week High and Low of Aarti Pharmalabs Ltd?
The 52-week high/low is the highest and lowest price at which a Aarti Pharmalabs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Aarti Pharmalabs Ltd is ₹320.3 and ₹662.8 as of 03 Jul ‘24
What is the CAGR of Aarti Pharmalabs Ltd?
Aarti Pharmalabs Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at 76.38%, 6 Month at 28.80%, 3 Month at 39.65% and 1 Month at 12.49%.
What is the shareholding pattern of Aarti Pharmalabs Ltd?
The shareholding pattern of Aarti Pharmalabs Ltd is as follows:
Promoters - 46.46 %
Institutions - 18.31 %
Public - 35.23 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
